,16,17 This is reflected in the emergence of similar toxicities (most frequently skin rashes) upon treatment with EGFR-directed mAbs and TKIs, respectively, despite highly dissimilar mechanisms of action of these two drug classes.15 Here, EGFR is linked to Skin rash.